Evidence map›Paper›PMID 34233055›Full record

ArticleClinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology2021

Identifying key priorities for research to protect the consumer with food hypersensitivity: A UK Food Standards Agency Priority Setting Exercise.

Paul J Turner, Elizabeth Andoh-Kesson, Sarah Baker, Alexa Baracaia, Alisha Barfield, Julie Barnett, Karen Brunas, Chun-Han Chan, Stella Cochrane, Katherine Cowan and 25 more

Open access · hybridAbstract read
In one paragraph

Article in Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Review
  3. Identifying key priorities for research to protect the consumer with food hypersensitivity: A UK Food Standards Agency Priority Setting Exercise.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

35 authors at 20 institutions in 2 countries.

Paul J TurnerNational Heart & Lung Institute, Imperial College London, London, UK.ORCID 0000-0001-9862-5161
Elizabeth Andoh-KessonBritish Retail Consortium, London, UK.
Sarah BakerAnaphylaxis Campaign, Farnborough, UK.
Alexa BaracaiaImperial College London, London, UK.
Alisha BarfieldFood Standards Agency, London, UK.
Julie BarnettDepartment of Psychology, University of Bath, Bath, UK.
Karen BrunasImperial College London, London, UK.
Chun-Han ChanFood Standards Agency, London, UK.
Stella CochraneUnilever Safety and Environmental Assurance Centre (SEAC, Sharnbrook, UK.
Katherine CowanKatherine Cowan Consulting, East Sussex, UK.
Mary FeeneyKing's College London, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Simon FlanaganReading Science Centre, Mondelēz International, UK.
Adam T FoxKing's College London, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Leigh GeorgeAllergy UK, Sidcup, UK.
M Hazel GowlandAllergy Action, St Albans, UK.
Christina HeeleyBarnsley Metropolitan Borough Council, Barnsley, UK.
Ian KimberFood Standards Agency, London, UK.
Rebecca KnibbAston University, Birmingham, UK.ORCID 0000-0001-5561-0904
Kirsty LangfordBath and North East Somerset Council, Bath, UK.
Alan MackieUniversity of Leeds, Leeds, UK.
Tim McLachlanNatasha Allergy Research Foundation, Isleworth, UK.
Lynne RegentAnaphylaxis Campaign, Farnborough, UK.
Matthew RiddPopulation Health Sciences, University of Bristol, Bristol, UK.ORCID 0000-0002-7954-8823
Graham RobertsClinical and Experimental Sciences Academic Unit, Faculty of Medicine, University of Southampton, Southampton, UK.ORCID 0000-0003-2252-1248
Adrian RogersRomer Labs UK, Ltd, Runcorn, UK.
Guy ScaddingRoyal Brompton & Harefield Hospital NHS Trust, London, UK.
Sarah StonehamImperial College London, London, UK.
Darryl ThomsonFood Experts Group, UK Hospitality, London, UK.
Heidi UrwinCoeliac UK, High Wycombe, UK.
Carina VenterSection of Allergy/Immunology, Children's Hospital Colorado and University of Colorado, Denver, CO, USA.
Michael WalkerOffice the Government Chemist, Teddington, UK.
Rachel WardExponent International Ltd, Harrogate, UK.
Ross A R YarhamFood Standards Agency, London, UK.
Maggie YoungAllergy UK, Sidcup, UK.
John O'BrienNutrition Innovation Centre for Food & Health, School of Biomedical Sciences, Ulster University, Coleraine, UK.
Food Standards Agency · GBImperial College London · GBAllergy Therapeutics (United Kingdom) · GBKing's College London · GBAllergy Action · GBAsthma and Allergy Foundation of America · USAston University · GBBarnsley Metropolitan Borough Council · GBBath and North East Somerset Council · GBBiomer Technology (United Kingdom) · GBChildren's Hospital Colorado · USCoeliac UK · GBEast Sussex County Council · GBFuture Science Group (United Kingdom) · GBGovernment of the United Kingdom · GBHarefield Hospital · GBMalaria Consortium · GBMondelēz International (United Kingdom) · GBUnilever (United Kingdom) · GBUniversity of Bath · GB

Funding

UK Food Standards Agency
6 · The paper itself

Abstract

introductionFood hypersensitivity (FHS), including food allergy, coeliac disease and food intolerance, is a major public health issue. The Food Standards Agency (FSA), an independent UK Government department working to protect public health and consumers' wider interests in food, sought to identify research priorities in the area of FHS.

methodsA priority setting exercise was undertaken, using a methodology adapted from the James Lind Alliance-the first such exercise with respect to food hypersensitivity. A UK-wide public consultation was held to identify unanswered research questions. After excluding diagnostics, desensitization treatment and other questions which were out of scope for FSA or where FSA was already commissioning research, 15 indicative questions were identified and prioritized by a range of stakeholders, representing food businesses, patient groups, health care and academia, local authorities and the FSA.

results295 responses were received during the public consultation, which were categorized into 70 sub-questions and used to define 15 key evidence uncertainties ('indicative questions') for prioritization. Using the JLA prioritization framework, this resulted in 10 priority uncertainties in evidence, from which 16 research questions were developed. These could be summarized under the following 5 themes: communication of allergens both within the food supply chain and then to the end consumer (ensuring trust in allergen communication); the impact of socio-economic factors on consumers with FHS; drivers of severe reactions; mechanism(s) underlying loss of tolerance in FHS; and the risks posed by novel allergens/processing. DISCUSSION: In this first research prioritization exercise for food allergy and FHS, key priorities identified to protect the food-allergic public were strategies to help allergic consumers to make confident food choices, prevention of FHS and increasing understanding of socio-economic impacts. Diagnosis and treatment of FHS was not considered in this prioritization.

Indexed as

Biomedical ResearchFood HypersensitivityHumansUnited Kingdomallergen labellingcoeliac diseasefood allergyJames Lind Allianceresearch prioritization

Identifiers

PMID34233055
PMCPMC9291826
OpenAlexW3181573915

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.